To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops
NCT01160133 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2012-04-10
Summary
This is a multi-site, randomized, investigator-masked study to evaluate the physical effects of Systane(R) versus Refresh Tears(R) in subjects with moderate to severe dry eye. It is a 6-week, perspective, randomized, active-controlled, investigator-masked, parallel group study.
Conditions
- Dry Eye
Interventions
- OTHER
-
Systane
Systane Lubricant Eye Drops (1-2 drops in each eye, four times per day)
- OTHER
-
Refresh Tears
Refresh Tears Lubricant Eye Drops (1-2 drops in each eye, four times per day)
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- India
Study Locations
More Related Trials
-
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
NCT03492541 ·Status: COMPLETED ·Phase: NA
-
Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency
NCT01688726 ·Status: COMPLETED ·Phase: NA
-
Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
NCT00345241 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief
NCT02455050 ·Status: COMPLETED ·Phase: PHASE3
-
SYSTANE® Family - Meibomian Deficiency
NCT01733745 ·Status: COMPLETED ·Phase: NA
-
Systane Clinical Experience Study
NCT00818909 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
NCT01657253 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease
NCT06188260 ·Status: COMPLETED ·Phase: PHASE2
-
Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops
NCT00610480 ·Status: COMPLETED ·Phase: NA
-
Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
NCT01382810 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects
NCT01718028 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA
-
Tear Lipid Layer Thickness With Emollient Eye Drops
NCT03380624 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes
NCT00704275 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects
NCT01967147 ·Status: COMPLETED ·Phase: NA
-
Artificial Tears Study in Mild to Moderate Dry Eye Patients
NCT00607776 ·Status: COMPLETED ·Phase: PHASE2
-
Artificial Tears, Tear Lipids and Tear Film Dynamics
NCT05705518 ·Status: COMPLETED ·Phase: PHASE4
-
SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease
NCT07243275 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT00622037 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye
NCT03183089 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome
NCT01541891 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP® MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye
NCT06686368 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4